Table 5.
Relative risk of mortality from liver diseases in women by serum aminotransferase concentration at baseline (expressed as floating absolute risks)
|
Total No of participants
|
Liver diseases
|
||
|---|---|---|---|
| No of deaths | RR*(95% CI) | ||
| AST (IU/I): | |||
| <20 | 25 362 | 3 | 1.0 (0.3 to 3.2) |
| 20-29 | 19 463 | 9 | 3.3 (1.7 to 6.4) |
| 30-39 | 2 114 | 6 | 18.2 (8.1 to 40.4) |
| 40-49 | 336 | 3 | 46.1 (14.9 to 147.4) |
| ≥50 | 247 | 2 | 46.2 (11.0 to 180.4) |
| ALT (IU/I): | |||
| <20 | 35 187 | 6 | 1.0 (0.4 to 2.3) |
| 20-29 | 10 201 | 8 | 3.8 (1.9 to 7.7) |
| 30-39 | 1 380 | 2 | 6.6 (1.5 to 25.6) |
| 40-49 | 365 | 5 | 68.3 (27.4 to 162.0) |
| ≥50 | 389 | 2 | 21.5 (5.3 to 85.6) |
AST=aspartate aminotransferase, ALT=alanine aminotransferase.
*
Adjusted for age, body mass index, smoking status, alcohol consumption, plasma glucose, serum total cholesterol, blood pressure, and family history of liver disease.